{
    "Trade/Device Name(s)": [
        "Cepheid Xpert MRSA NxG Control Panel"
    ],
    "Submitter Information": "Microbiologics, Inc.",
    "510(k) Number": "K191172",
    "Predicate Device Reference 510(k) Number(s)": [
        "K182472"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PMN"
    ],
    "Summary Letter Date": "June 20, 2019",
    "Summary Letter Received Date": "May 1, 2019",
    "Submission Date": "April 30, 2019",
    "Regulation Number(s)": [
        "21 CFR 866.3920"
    ],
    "Regulation Name(s)": [
        "Assayed Quality Control Material For Clinical Microbiology Assays"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Methicillin-Resistant Staphylococcus aureus",
        "Staphylococcus epidermidis"
    ],
    "Specimen Type(s)": [],
    "Specimen Container(s)": [
        "Heat-sealed foil pouch"
    ],
    "Instrument(s)/Platform(s)": [
        "GeneXpert Instrument System"
    ],
    "Method(s)/Technology(ies)": [
        "Nucleic acid extraction",
        "Amplification",
        "Detection"
    ],
    "Methodologies": [
        "Qualitative nucleic acid testing"
    ],
    "Submission Type(s)": [
        "Quality control material",
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for Cepheid Xpert MRSA NxG Control Panel, an external assayed quality control panel for use with Cepheid Xpert MRSA NxG Assay on the GeneXpert Instrument System",
    "Indications for Use Summary": "Intended as external assayed positive and negative quality controls to monitor qualitative detection of Methicillin-Resistant Staphylococcus aureus with Cepheid Xpert MRSA NxG Assay on the GeneXpert Instrument System",
    "fda_folder": "Microbiology"
}